LONDON (Reuters) – European private equity fund CVC and Singaporean sovereign wealth fund Temasek are to buy a controlling stake in the pharmaceutical firm Alvogen, its chairman and chief executive said.
EXCLUSIVE - CVC and Temasek to buy $2 billion generic drugs firm Alvogen
No comments:
Post a Comment